Fatty Liver: all 1,462 studies
Page 15 of 15. Open to participants first (289), then studies with results posted, then the rest; newest registration first within each.
- Evaluation of Intestinal Microbiome in Obese KidsWithdrawnNCT00816296
- Evaluation of Diet and Exercise in Patients With Non-Alcoholic Fatty Liver DiseaseCompletedNCT00815009Not applicable
- The Effect of Probiotics on Non Alcoholic Fatty Liver DiseaseTerminatedNCT00808990Phase 1
- PK of NRL972 in Patients with Nonalcoholic Steatohepatitis (NASH) and Non-Alcoholic Fatty Liver Disease (NAFLD)CompletedNCT00794716Phase 2
- Exercise Dose and Nonalcoholic Fatty Liver DiseaseCompletedNCT00771108Not applicable
- Safety, Tolerability, Pharmacokinetics and Activity of GS-9450 in Adults With Non-Alcoholic Steatohepatitis (NASH)CompletedNCT00740610Phase 2
- Fatty Liver and Obstructive Sleep ApneaCompletedNCT00730873Not applicable
- De Novo Lipogenesis, Lipid and Carbohydrate Metabolism in Non-alcoholic Fatty Liver DiseaseCompletedNCT00714129Not applicable
- Phase 1 Pharmacokinetic Study Of CP-945598 In Patients With NASHCompletedNCT00706537Phase 1
- Rosiglitazone Versus Rosiglitazone and Metformin Versus Rosiglitazone and Avandia in the Treatment of Nonalcoholic Steatohepatitis (NASH)Status unknownNCT00699036Phase 2
- Study of Fish Oil to Reduce ALT Levels in AdolescentsTerminatedNCT00694746Phase 1
- Omega 3 Fish Oil Supplements vs. Placebo for Patients With Non-alcoholic Steatohepatitis (NASH)CompletedNCT00681408Phase 2/3
- A Pilot Study of Acarbose as Treatment for Pediatric Non-alcoholic Fatty Liver Disease (NAFLD)TerminatedNCT00677521Phase 2
- Development of Biomarker for Development of Non-Alcoholic Steatohepatitis (NASH) in ChildrenWithdrawnNCT00677183
- Losartan and Simvastatin in Hypertensive Obeses With Liver SteatosisStatus unknownNCT00669435Phase 4
- A Proof-of-principle Study of Oral Treatment of Non-alcoholic Steatohepatitis With a Novel PDE4 Inhibitor ASP9831CompletedNCT00668070Phase 2
- Effect of Iron Depletion by Phlebotomy Plus Lifestyle Changes vs. Lifestyle Changes Alone on Liver Damage in Patients With Nonalcoholic Fatty Liver Disease With Increased Iron StoresStatus unknownNCT00658164Phase 3
- Effect of Vitamin E on Pediatric Nonalcoholic Fatty Liver Disease (NAFLD)CompletedNCT00655018Phase 2/3
- Evaluation of Phlebotomy as a Treatment for Non-alcoholic Fatty Liver DiseaseCompletedNCT00641524Not applicable
- Insulin Resistance in Nonalcoholic Fatty Liver Disease: A Case Control StudyTerminatedNCT00637520
- Role of Pioglitazone and Berberine in Treatment of Non-Alcoholic Fatty Liver DiseaseCompletedNCT00633282Phase 2
- MRI to Measure Liver Fat ContentCompletedNCT00594412Not applicable
- Betaine in Patients With Nonalcoholic SteatohepatitisCompletedNCT00586911Phase 2
- Effects of Alanine in Patients With Nonalcoholic SteatohepatitisCompletedNCT00586885Not applicable
- Effects of Weight Loss on Hepatic and Muscle Lipid Content and on Insulin Sensitivity on Obese Adolescents With NAFLDCompletedNCT00585299Not applicable
- The Role of Leptin Receptors in NASHCompletedNCT00583999
- An Efficacy and Safety Study of Rimonabant for Treatment of Nonalcoholic Steatohepatitis (NASH) in Patients With Type 2 DiabetesTerminatedNCT00577148Phase 3
- Non Alcoholic Fatty Liver Disease (NAFLD) in Hong KongStatus unknownNCT00577044
- An Efficacy and Safety Study of Rimonabant for Treatment of Nonalcoholic Steatohepatitis (NASH) in Patients Without DiabetesTerminatedNCT00576667Phase 3
- Relationship of Metabolic Abnormalities to Hepatic Steatosis in HIVCompletedNCT00575757
- Transoral Endoscopic Liver Biopsy During Laparoscopic Gastric BypassCompletedNCT00512512
- Efficacy and Safety of Viusid in Patients With Nonalcoholic SteatohepatitisCompletedNCT00509418Phase 3
- A One-Year, Randomized, Double-Blind, Placebo-Controlled Trial of Rosiglitazone in Non-Alcoholic SteatohepatitisCompletedNCT00492700Phase 2
- Observational Study of Early Metabolic and Vascular Changes in ObesityStatus unknownNCT00482924
- Effects of a Low Glycemic Load Diet on Fatty Liver in ChildrenCompletedNCT00480922Not applicable
- Growth Hormone During Fasting.Signaltransduktion in Muscle and Adipose Tissue and Changes in Intrahepatic Lipid ContentCompletedNCT00476879Not applicable
- Fatty Liver in PregnancyStatus unknownNCT00471575
- Pilot Study of Ursodesoxycholic Acid in Non-Alcoholic SteatohepatitisCompletedNCT00470171Phase 2
- Novel Therapies for Metabolic Complications of LipodystrophiesCompletedNCT00457938Not applicable
- Oxidative Stress and Fatty Acids in Hepatitis CCompletedNCT00444002
- Quantification of Liver Iron Overload and Steatosis Using Magnetic Resonance ImagingCompletedNCT00401336Not applicable
- Phase I Trial of Silymarin for Chronic Liver DiseasesCompletedNCT00389376Phase 1
- Non Alcoholic Fatty Liver Disease Influence of Statin TherapyWithdrawnNCT00375349Not applicable
- Liver Fibrosis in HIV-Infected Patients With Elevated Liver Enzymes on Antiretroviral TherapyCompletedNCT00326482
- Metformin in Non-Alcoholic Fatty Liver DiseaseStatus unknownNCT00303537Phase 2/3
- Assessing the Efficacy and Safety of Rosiglitazone Added to Standard Therapy for Hepatitis C Genotype 1 With Fatty LiverTerminatedNCT00274495Phase 4
- Nonalcoholic Fatty Liver Disease in Taiwanese ChildrenCompletedNCT00274183
- Weight Management in Nonalcoholic SteatohepatitisCompletedNCT00266019Phase 2
- Metformin in Patients With Non-Alcoholic Fatty Liver Disease (NAFLD)Status unknownNCT00247117Not applicable
- Development of a Breath Test for Monitoring Patients With Liver DiseaseCompletedNCT00244569Phase 3
- Relation of Obesity With Frequency of Meals (MST 0557)CompletedNCT00229255Not applicable
- Role of Pioglitazone in the Treatment of Non-alcoholic Steatohepatitis (NASH)CompletedNCT00227110Phase 4
- Study for the Treatment of Significant Steatosis With Xenical Followed by Treatment of Hepatitis C With Pegasys/CopegusCompletedNCT00207311Phase 4
- Quantitative Diagnosis of Fatty Liver by Dual Energy CT TechniqueStatus unknownNCT00172705
- Orlistat (Xenical) in the Treatment of Overweight Patients With Nonalcoholic Steatohepatitis (NASH)CompletedNCT00160407Phase 4
- Non-alcoholic Fatty Liver Disease (NAFLD) in HIV: The Role of Nutritional InterventionsTerminatedNCT00152815Phase 2
- Impact of nCPAP Treatment on Liver Function in Patients With Sleep Apnea Syndrome and Nonalcoholic SteatohepatitisStatus unknownNCT00152711Not applicable
- S-Adenosylmethionine Therapy for Non-Alcoholic SteatohepatitisCompletedNCT00108589Phase 3
- The Effect of a Probiotic on Hepatic SteatosisTerminatedNCT00099723Phase 1
- The Effect of Good Bacteria on Nonalcoholic Fatty Liver Disease in DiabeticsTerminatedNCT00068094Phase 1/2
- Treatment of Nonalcoholic Steatohepatitis With PioglitazoneCompletedNCT00013598Phase 2
- Randomized Study of the Use of Intravenous Choline Supplementation in Long Term Total Parenteral NutritionCompletedNCT00004697Not applicable